Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
פורמט:	Article
שפה:	Russian
יצא לאור:	LLC "Publishing House OKI" 2024-06-01
סדרה:	Антибиотики и Химиотерапия
נושאים:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
גישה מקוונת:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

פריטים דומים

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
מאת: M. M. Baranova, et al.
יצא לאור: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
מאת: D. V. Bukhanova, et al.
יצא לאור: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
מאת: Alyssa Howren, et al.
יצא לאור: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
מאת: Matthew Carroll, et al.
יצא לאור: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
מאת: Svedbom A, et al.
יצא לאור: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
מאת: Zlatković-Švenda Mirjana, et al.
יצא לאור: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
מאת: Hermine Leroi, et al.
יצא לאור: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
מאת: I Z Gaydukova, et al.
יצא לאור: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
מאת: Takacs P, et al.
יצא לאור: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
מאת: Joshua L. Lee, et al.
יצא לאור: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
מאת: M. M. Baranova, et al.
יצא לאור: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
מאת: M. Rossini, et al.
יצא לאור: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
מאת: Taras S. Panevin, et al.
יצא לאור: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
מאת: I. Pantano, et al.
יצא לאור: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
מאת: Milena Iwaszko, et al.
יצא לאור: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
מאת: Viola Sacchi, et al.
יצא לאור: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
מאת: Krzysztof Bonek, et al.
יצא לאור: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
מאת: Santhi Mantravadi, et al.
יצא לאור: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
מאת: Philip Brenner, et al.
יצא לאור: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
מאת: E. E. Gubar, et al.
יצא לאור: (2023-08-01)

Nod-like receptors in inflammatory arthritis
מאת: Sahib Singh Madahar, et al.
יצא לאור: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
מאת: Xinlin Nie, et al.
יצא לאור: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
מאת: M. Elaine Husni, et al.
יצא לאור: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
מאת: Christian Dejaco, et al.
יצא לאור: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
מאת: D. V. Bukhanova, et al.
יצא לאור: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
מאת: Eleonora Alina Dragomir-Lica, et al.
יצא לאור: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
מאת: Hanna Park, et al.
יצא לאור: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
מאת: Acar M, et al.
יצא לאור: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
מאת: Yu. V. Muravyev, et al.
יצא לאור: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
מאת: Noemí Martínez-López de Castro, et al.
יצא לאור: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
מאת: Sotaro Nakajima, et al.
יצא לאור: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
מאת: Andrea Picchianti-Diamanti, et al.
יצא לאור: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
מאת: Giovanni Cioffi, et al.
יצא לאור: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
מאת: I. Z. Gaidukova, et al.
יצא לאור: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
מאת: Zlatković-Švenda Mirjana I., et al.
יצא לאור: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
מאת: R. M. Balabanova, et al.
יצא לאור: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
מאת: Muhammad Haroon, et al.
יצא לאור: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
מאת: Jaroslaw Nowakowski, et al.
יצא לאור: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
מאת: Tacjana Anna Barczyńska, et al.
יצא לאור: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
מאת: T. V. Dubinina, et al.
יצא לאור: (2023-02-01)